News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
282,571 Results
Type
Article (14979)
Company Profile (300)
Press Release (267286)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (80158)
Career Advice (166)
Deals (13404)
Drug Delivery (39)
Drug Development (50748)
Employer Resources (31)
FDA (5854)
Job Trends (5185)
News (145518)
Policy (10097)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (938)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (21822)
ALS (124)
Alzheimer's disease (1034)
Antibody-drug conjugate (ADC) (241)
Approvals (6050)
Artificial intelligence (258)
Autoimmune disease (110)
Automation (9)
Bankruptcy (106)
Best Places to Work (4577)
BIOSECURE Act (6)
Biosimilars (101)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (344)
Cancer (3128)
Cardiovascular disease (237)
Career advice (150)
Career pathing (7)
CAR-T (217)
CDC (5)
Cell therapy (564)
Cervical cancer (14)
Clinical research (43705)
Collaboration (1148)
Company closure (2)
Compensation (593)
Complete response letters (39)
COVID-19 (1104)
CRISPR (86)
C-suite (551)
Cystic fibrosis (112)
Data (4324)
Denatured (15)
Depression (92)
Diabetes (254)
Diagnostics (1404)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (187)
Drug pricing (49)
Drug shortages (4)
Duchenne muscular dystrophy (213)
Earnings (31719)
Editorial (25)
Employer branding (4)
Employer resources (29)
Events (51849)
Executive appointments (622)
FDA (7606)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (984)
Gene editing (182)
Generative AI (21)
Gene therapy (487)
GLP-1 (505)
Government (1155)
Grass and pollen (3)
Guidances (166)
Healthcare (6664)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (39)
Indications (66)
Infectious disease (1211)
Inflammatory bowel disease (155)
Inflation Reduction Act (10)
Influenza (41)
Intellectual property (166)
Interviews (18)
IPO (7374)
IRA (13)
Job creations (870)
Job search strategy (132)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (245)
Leadership (9)
Legal (1412)
Liver cancer (41)
Longevity (11)
Lung cancer (419)
Lymphoma (248)
Machine learning (24)
Management (7)
Manufacturing (376)
MASH (130)
Medical device (2683)
Medtech (2693)
Mergers & acquisitions (6655)
Metabolic disorders (725)
Multiple sclerosis (102)
NASH (13)
Neurodegenerative disease (229)
Neuropsychiatric disorders (70)
Neuroscience (1955)
Neurotech (1)
NextGen: Class of 2026 (2062)
Non-profit (899)
Now hiring (30)
Obesity (329)
Opinion (125)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (161)
Parkinson's disease (232)
Partnered (12)
Patents (301)
Patient recruitment (328)
Peanut (43)
People (26793)
Pharmaceutical (45)
Pharmacy benefit managers (6)
Phase 1 (15491)
Phase 2 (20305)
Phase 3 (12830)
Pipeline (3241)
Policy (91)
Postmarket research (855)
Preclinical (6542)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (648)
Real estate (1460)
Recruiting (12)
Regulatory (9905)
Reports (19)
Research institute (979)
Resumes & cover letters (19)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (182)
Series B (137)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2015)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (334)
Venture capital (69)
Weight loss (174)
Women's health (25)
Worklife (2)
Date
Today (3)
Last 7 days (345)
Last 30 days (1283)
Last 365 days (17858)
2026 (1658)
2025 (18127)
2024 (20603)
2023 (22475)
2022 (26880)
2021 (27880)
2020 (23474)
2019 (16324)
2018 (11807)
2017 (13784)
2016 (11892)
2015 (14416)
2014 (10433)
2013 (7514)
2012 (7561)
2011 (7648)
2010 (7443)
Location
Africa (158)
Alabama (65)
Alaska (2)
Arizona (73)
Arkansas (6)
Asia (18271)
Australia (3126)
California (7083)
Canada (1836)
China (773)
Colorado (246)
Connecticut (252)
Delaware (235)
Europe (39242)
Florida (902)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (398)
India (35)
Indiana (162)
Iowa (8)
Japan (222)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (737)
Massachusetts (5587)
Michigan (110)
Minnesota (248)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (33)
New Hampshire (21)
New Jersey (1658)
New Mexico (13)
New York (1761)
North Carolina (825)
North Dakota (6)
Northern California (3475)
Ohio (177)
Oklahoma (11)
Oregon (24)
Pennsylvania (1277)
Puerto Rico (9)
Rhode Island (25)
South America (217)
South Carolina (10)
Southern California (2811)
Tennessee (40)
Texas (905)
United States (23370)
Utah (103)
Virginia (136)
Washington D.C. (37)
Washington State (592)
West Virginia (1)
Wisconsin (45)
282,571 Results for "knight therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Solventum Appoints Heather Knight as Chief Commercial Officer
October 21, 2025
·
6 min read
Press Releases
Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight
November 10, 2025
·
7 min read
C-suite
Caught In Sarepta ‘Downdraft,’ Arrowhead Becomes RNAi Knight in Shining Armor
Sarepta’s troubles had nothing to do with Arrowhead’s assets, and yet both companies have seen their stock prices decline this past month.
BioSpace
caught up with Arrowhead’s Chris Anzalone to talk about the biotech’s role as an RNAi pipeline savior.
August 12, 2025
·
7 min read
·
Annalee Armstrong
Press Releases
Univec, Inc. Welcomes Michael Knight to Board of Directors
January 17, 2025
·
1 min read
BioMidwest
Asha Therapeutics Selected as a BLUE KNIGHT™ Company by Johnson & Johnson Innovation and the Biomedical Advanced Research and Development Authority (BARDA)
Asha Therapeutics announced today that it has been selected as a BLUE KNIGHT™ company.
September 22, 2023
·
3 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Press Releases
Waters Corporation Appoints Heather Knight to Board of Directors
August 15, 2024
·
2 min read
BioForest
HDT Bio Receives $1 Million Award from BLUE KNIGHT™ Resident QuickFire Challenge in Support of Project NextGen
HDT Bio Corp. announced that it has received a $1 million award from the BLUE KNIGHT™ Resident QuickFire Challenge.
October 4, 2023
·
2 min read
Press Releases
Decoy Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
February 5, 2026
·
4 min read
Genetown
Adrestia Co-Founder Professor Steve Jackson Named Knight Bachelor for Services to Innovation and Research
Adrestia Therapeutics announced its co-founder, Professor Steve Jackson FRS FMedSci, has been named a Knight Bachelor in the 2023 Birthday Honours List, which announces the bestowing of various awards and designations on the King’s Birthday in the United Kingdom.
June 16, 2023
·
4 min read
1 of 28,258
Next
